ArticleCurrent oncology (Toronto, Ont.)2023

Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer.

Lucas Delmonico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.